PEXL - Pacer US Export Leaders ETF
| Assets | $2.00M |
| NAV | $40.05 |
| Expense Ratio | 0.60% |
| PE Ratio | 29.61 |
| Beta (5Y) | 1.20 |
| Dividend (ttm) | $0.15 |
| Dividend Yield | 0.38% |
| Ex-Dividend Date | Mar 22, 2021 |
| 1-Year Return | - |
| Trading Day | April 20 |
| Last Price | $39.88 |
| Previous Close | $40.29 |
| Change ($) | -0.41 |
| Change (%) | -1.03% |
| Day's Open | - |
| Day's Range | 39.88 - 40.31 |
| Day's Volume | 13 |
| 52-Week Range | 23.51 - 40.75 |
Fund Description
The investment seeks to track the total return performance, before fees and expenses, of the Pacer US Export Leaders Index (the index). The fund invests at least 80% of its total assets (exclusive of collateral held from securities lending) in the component securities of the index. The index uses an objective, rules-based methodology to measure the performance of an equal weight portfolio of approximately 100 large- and mid-capitalization U.S. companies with a high percentage of foreign sales and high free cash flow growth. Free cash flow is a company's cash flow from operations minus its capital expenditures. The fund is non-diversified.
| Asset Class Equity | Inception Date Jul 23, 2018 |
| Exchange NYSEARCA | Ticker Symbol PEXL |
| Index Tracked Pacer US Export Leaders Index | |
Top 10 Holdings
11.32% of assets| Name | Symbol | Weight |
|---|---|---|
| Lam Research | LRCX | 1.19% |
| STAAR Surgical | STAA | 1.17% |
| Applied Materials | AMAT | 1.17% |
| KLA Corporation | KLAC | 1.14% |
| Teradyne | TER | 1.12% |
| MKS Instruments | MKSI | 1.12% |
| FB | 1.12% | |
| CMC Materials | CCMP | 1.11% |
| NXP Semiconductors | NXPI | 1.11% |
| Mettler-Toledo | MTD | 1.08% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Mar 22, 2021 | $0.015 | Mar 26, 2021 |
| Dec 21, 2020 | $0.054 | Dec 28, 2020 |
| Sep 21, 2020 | $0.047 | Sep 25, 2020 |
| Jun 22, 2020 | $0.036 | Jun 26, 2020 |
| Mar 23, 2020 | $0.035 | Mar 27, 2020 |
| Dec 24, 2019 | $0.039 | Dec 27, 2019 |
News
After a monster rally, Wall Street seems to be losing steam on fading euphoria on vaccine rollout. Is this the time to be cautious and bet on quality ETFs?